The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kyowa Hakko Kirin
Quality of life in cutaneous T-cell lymphoma subjects treated with anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from the phase 3 MAVORIC trial.
 
Pierluigi Porcu
Honoraria - Actelion; Celgene
Consulting or Advisory Role - Innate Pharma
Research Funding - Celgene (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); OncoMed (Inst); Seagen (Inst)
 
Stacie Hudgens
Research Funding - Clinical Outcomes Solutions (Inst)
Travel, Accommodations, Expenses - Eisai
 
Pietro Quaglino
Honoraria - Actelion; Innate Pharma; Kyowa Hakko Kirin; Takeda; Therakos
Consulting or Advisory Role - Actelion; Innate Pharma; Kyowa Hakko Kirin; Takeda
Travel, Accommodations, Expenses - Actelion; Innate Pharma; Kyowa Hakko Kirin; Takeda; Therakos
 
Richard Cowan
Honoraria - Takeda
Consulting or Advisory Role - Takeda
Travel, Accommodations, Expenses - Takeda
 
Lysbeth Floden
Research Funding - Clinical Outcomes Solutions (Inst)
 
Mollie Leoni
No Relationships to Disclose
 
Stephen Dale
Employment - Kyowa Hakko Kirin
 
Madeleine Duvic
Honoraria - Cell Medica; Clinical Care Options/NCCN; Concert Pharmaceuticals; Defined Health; Dr. Reddy's Laboratories; Evidera; Forty Seven; Guidepoint Global; Huron Consulting; Jonathan Wood and Associates; Kiniksa; Lynx Group; Mallinckrodt; MedaCorp; Medivir; Medscape; Millennium; miRagen; Precision Oncology; Soligenix; Taiwan Liposome
Consulting or Advisory Role - Cell Medica; Clinical Care Options/NCCN; Concert Pharmaceuticals; Defined Health; Dr. Reddy's Laboratories; Evidera; Forty Seven; Guidepoint Global; Huron Consulting; Jonathan Wood and Associates; Kiniksa; Lynx Group; Mallinckrodt; MedaCorp; Medivir; Medscape; Millennium; miRagen; Precision Oncology; Soligenix; Taiwan Liposome
Travel, Accommodations, Expenses - Cell Medica; Clinical Care Options/NCCN; Concert Pharmaceuticals; Defined Health; Dr. Reddy's Laboratories; Evidera; Forty Seven; Guidepoint Global; Huron Consulting; Jonathan Wood and Associates; Kiniksa; Lynx Group; Mallinckrodt; MedaCorp; Medivir; Medscape; Millennium; miRagen; Precision Oncology; Soligenix; Taiwan Liposome